CXMT's DRAM Surge Triggers Broad Sell-Off in Major U.S. Chip Stocks

Micron Technology shares slid about 8% on July 15 to around $903.50 as investors confronted a shifting backdrop in memory chips: China's DRAM industry is no longer a footnote. It's becoming a serious rival. The pressure point was ChangXin Memory Technologies (CXMT), which has been steadily expanding its footprint in the global DRAM market while U.S. and other Western chip names were riding AI-driven earnings momentum. The move hit the broader semiconductor complex. AMD and Intel fell roughly 6% each, Marvell dropped about 7%, and the iShares Semiconductor ETF (SOXX) declined 4%. CXMT is estimated to have taken about 8% of the global DRAM market in Q1 2026, up from roughly 3% a year earlier, a near tripling of share in less than 12 months. Additional reports that Apple has been testing CXMT-produced chips for devices sold in China intensified the market reaction. On July 27, CXMT listed on Shanghai's STAR Market, raising an estimated $8.6 billion to $9.8 billion. The stock surged 466% in its debut session, briefly making CXMT China's most valuable listed company, with a market capitalization estimated between $487 billion and $540 billion. Micron's own operating results paint a different picture. The company posted what it described as one of the strongest quarters on record for the sector, with fiscal Q3 2026 revenue of $41.46 billion, up 346% year over year. Micron guided fiscal Q4 revenue to roughly $50 billion. Some analysts argue the near-term competitive threat from CXMT may be overstated. In that view, the pullback looks more like profit-taking after Micron's earnings-driven rally, with CXMT serving as a convenient narrative hook. The implications extend beyond individual chip stocks. U.S. export controls were designed to keep China at least a generation behind in advanced semiconductors. CXMT's rapid gains in DRAM, even if not at the leading edge of high-bandwidth memory used in AI accelerators, underscore the limits of containment. If CXMT's expanding capacity contributes to DRAM oversupply and price compression, it could reshape cost structures across the AI infrastructure buildout. The scale of CXMT's IPO, potentially the largest of 2026, also signals a major capital infusion into China's semiconductor push. Close to $10 billion in new funding could translate into more fabrication capacity, heavier R&D spending, and more aggressive pricing. Investors tracking the theme are focusing on two key questions: whether Apple's CXMT testing moves beyond China-market devices, and whether CXMT directs post-IPO capital toward higher-performance memory segments.